Prenatal Risk Assessment



tox.JPG (37169 bytes)

MCL Laboratories





MCL Pathology Services



The prenatal risk assessment (also called the "triple screen") is a group  of assays (AFP, BHCG and unconjugated Estriol (uE3)) in conjunction with prenatal risk assessment software to calculate risk for Down's Syndrome, Trisomy 18, and Neural tube defects. The testing is performed on a serum sample collected between weeks 15-21 (15 weeks 0 days to 20 weeks 6 days) of gestation.

MCL Web Resources a TCM Project

last revised 12/12/2005